News

New solution will address needs in oncology clinical research, with a special focus on emerging biotechs.

Solutions include pre-configured modules for vaccine clinical trials that increase operational efficiency.

New partnership will advance multiple myeloma drug discovery and clinical development.

New partnership will accelerate Phase III study in patients with atrial fibrillation.

CRO expands its Early Phase large molecule capabilities and services with a new 15,000 square foot dedicated lab.

Study focuses on three major therapy areas; neurology, oncology, and cardiology, which digital biomarkers impact.

Company offers physician and patient platform access.

The latest business and people happenings of the last month, all in one place.

AWS customers now have access to SEQSTER's operating system for patient registries and clinical studies.

As part of multi-year agreement, Saama will add machine learning tech to Merck's clinical development process.

New partnership to offer integrated clinical trial supply labeling and packaging capabilities.

Industry now leveraging reporting system to empower patients and improve research.

Organizations jointly release resources to help research sites increase racial and ethnic equity, diversity, and inclusion in cancer trials.

Lokavant will provide performance data on global trial sites and principal investigators.

Survey among readers evaluates the trajectory of RWD and how it can be more widely adopted.

Krka to use upgraded Calyx RIM, now on Microsoft Azure, for an additional five years.

Patients in all studies can consent to longitudinal data use to accelerate RWE

Two independent, publicly-traded companies will result upon completion.

Cancer Moonshot Biobank relies on Medidata's eConsent and EDC platforms.

Audio and video recording and compliance enhancements among new changes to platform.

Howard University College of Pharmacy will now offer a two-year post-professional Doctorate in Pharmacy fellowship program.

Partnership to enable AI-enhanced medical imaging services for CNS clinical trials.

New services added to CRO’s early phase business to better serve customers.

Partnership will expand Sharp's reach to China.

Partnership to expand availability of clinical trials to over 20 hospitals and medical sites.

Service will utilize blockchain technology and enable certification of key documents.

The latest business and people happenings from the last month, all in one place.

DHA's PTSD Drug Treatment Program will deploy AiCure's adherence and digital biomarker solutions.